These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Precursor-Independent Overproduction of Beta-Amyloid in AD: Mitochondrial Dysfunction as Possible Initiator of Asymmetric RNA-Dependent βAPP mRNA Amplification. An Engine that Drives Alzheimer's Disease. Volloch V; Olsen BR; Rits S Ann Integr Mol Med; 2019; 1(1):61-74. PubMed ID: 31858090 [TBL] [Abstract][Full Text] [Related]
8. Genomic mosaicism with increased amyloid precursor protein (APP) gene copy number in single neurons from sporadic Alzheimer's disease brains. Bushman DM; Kaeser GE; Siddoway B; Westra JW; Rivera RR; Rehen SK; Yung YC; Chun J Elife; 2015 Feb; 4():. PubMed ID: 25650802 [TBL] [Abstract][Full Text] [Related]
9. Mutations in amyloid precursor protein and presenilin-1 genes increase the basal oxidative stress in murine neuronal cells and lead to increased sensitivity to oxidative stress mediated by amyloid beta-peptide (1-42), HO and kainic acid: implications for Alzheimer's disease. Mohmmad Abdul H; Sultana R; Keller JN; St Clair DK; Markesbery WR; Butterfield DA J Neurochem; 2006 Mar; 96(5):1322-35. PubMed ID: 16478525 [TBL] [Abstract][Full Text] [Related]
10. On the identification of low allele frequency mosaic mutations in the brains of Alzheimer's disease patients. Sala Frigerio C; Lau P; Troakes C; Deramecourt V; Gele P; Van Loo P; Voet T; De Strooper B Alzheimers Dement; 2015 Nov; 11(11):1265-76. PubMed ID: 25937274 [TBL] [Abstract][Full Text] [Related]
11. Regional brain iron associated with deterioration in Alzheimer's disease: A large cohort study and theoretical significance. Ayton S; Portbury S; Kalinowski P; Agarwal P; Diouf I; Schneider JA; Morris MC; Bush AI Alzheimers Dement; 2021 Jul; 17(7):1244-1256. PubMed ID: 33491917 [TBL] [Abstract][Full Text] [Related]
12. Regional distribution of synaptic markers and APP correlate with distinct clinicopathological features in sporadic and familial Alzheimer's disease. Shinohara M; Fujioka S; Murray ME; Wojtas A; Baker M; Rovelet-Lecrux A; Rademakers R; Das P; Parisi JE; Graff-Radford NR; Petersen RC; Dickson DW; Bu G Brain; 2014 May; 137(Pt 5):1533-49. PubMed ID: 24625695 [TBL] [Abstract][Full Text] [Related]
13. Abundance of Aβ₅-x like immunoreactivity in transgenic 5XFAD, APP/PS1KI and 3xTG mice, sporadic and familial Alzheimer's disease. Guzmán EA; Bouter Y; Richard BC; Lannfelt L; Ingelsson M; Paetau A; Verkkoniemi-Ahola A; Wirths O; Bayer TA Mol Neurodegener; 2014 Apr; 9():13. PubMed ID: 24694184 [TBL] [Abstract][Full Text] [Related]
14. AD "Statin": Alzheimer's Disorder is a "Fast" Disease Preventable by Therapeutic Intervention Initiated Even Late in Life and Reversible at the Early Stages. Volloch V; Olsen BR; Rits S Ann Integr Mol Med; 2020; 2(1):75-89. PubMed ID: 32201863 [TBL] [Abstract][Full Text] [Related]
15. Results of Beta Secretase-Inhibitor Clinical Trials Support Amyloid Precursor Protein-Independent Generation of Beta Amyloid in Sporadic Alzheimer's Disease. Volloch V; Rits S Med Sci (Basel); 2018 Jun; 6(2):. PubMed ID: 29865246 [TBL] [Abstract][Full Text] [Related]
16. Detection of APP gene recombinant in human blood plasma. Mitsunaga S; Fujito N; Nakaoka H; Imazeki R; Nagata E; Inoue I Sci Rep; 2023 Dec; 13(1):21703. PubMed ID: 38066066 [TBL] [Abstract][Full Text] [Related]